Back to Search
Start Over
Prognostic factors of paraneoplastic pemphigus.
- Source :
-
Archives of dermatology [Arch Dermatol] 2012 Oct; Vol. 148 (10), pp. 1165-72. - Publication Year :
- 2012
-
Abstract
- Objective: To identify the prognostic factors of overall survival in a series of patients with paraneoplastic pemphigus (PNP).<br />Design: Multicenter retrospective cohort study.<br />Setting: Twenty-seven dermatology departments in France.<br />Patients: A total of 53 patients (31 men and 22 women; median age, 59 years; age range, 30-88 years) were diagnosed as having PNP between 1992 and 2010.<br />Main Outcome Measures: Overall Kaplan-Meier survival rates were estimated, and features associated with survival were assessed using univariate (log-rank test) and multivariate (Cox regression) analyses.<br />Results: The study included 53 patients with PNP. Thirty-six patients (68%) died during the study. The 1-, 3-, and 5-year overall survival rates were 49%, 41%, and 38%, respectively. The main causes of death were infections (n=21) and evolution of neoplasia (n=6). In univariate analysis, the main detrimental prognostic factors identified were erythema multiforme–like skin lesions (P=.05) and histologic keratinocyte necrosis (P=.03). None of the 5 patients with Castleman disease died during the study. After adjustment for age and sex in multivariate analysis, erythema multiforme–like skin lesions remained predictive of fatal outcome, with a 2-fold increase in death rate (hazard ratio [HR], 2.3; 95% CI, 1.05-5.03; P=.04). The prognosis of patients with PNP was even poorer when erythema multiforme–like skin lesions were associated with severe skin or mucosal involvement at presentation (HR of death, 3.0; 95% CI, 1.01-8.92; P=.049).<br />Conclusion: Patients with PNP with erythema multiforme–like skin lesions and histologic keratinocyte necrosis, especially when associated with extensive lesions at presentation, are likely to have a more severe and rapid fatal outcome and should be managed very carefully.
- Subjects :
- Adrenal Cortex Hormones therapeutic use
Adult
Aged
Aged, 80 and over
Antibodies, Monoclonal, Murine-Derived therapeutic use
Autoantibodies blood
Carrier Proteins immunology
Cytoskeletal Proteins immunology
Desmoplakins immunology
Dystonin
Female
Humans
Immunologic Factors therapeutic use
Immunosuppressive Agents therapeutic use
Kaplan-Meier Estimate
Male
Membrane Proteins immunology
Middle Aged
Mucous Membrane pathology
Multivariate Analysis
Nerve Tissue Proteins immunology
Paraneoplastic Syndromes drug therapy
Paraneoplastic Syndromes immunology
Pemphigus drug therapy
Pemphigus immunology
Plakins immunology
Prognosis
Proportional Hazards Models
Protein Precursors immunology
Retrospective Studies
Rituximab
Severity of Illness Index
Erythema Multiforme pathology
Neoplasms complications
Paraneoplastic Syndromes pathology
Pemphigus pathology
Subjects
Details
- Language :
- English
- ISSN :
- 1538-3652
- Volume :
- 148
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- Archives of dermatology
- Publication Type :
- Academic Journal
- Accession number :
- 22801794
- Full Text :
- https://doi.org/10.1001/archdermatol.2012.1830